rs200116252
Variant summary
Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4BS2
The NM_018100.4(EFHC1):c.1385T>C(p.Ile462Thr) variant causes a missense change. The variant allele was found at a frequency of 0.0001 in 1,614,124 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_018100.4 missense
Scores
Clinical Significance
Conservation
Publications
- juvenile myoclonic epilepsyInheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
- epilepsyInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -5 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| EFHC1 | NM_018100.4 | c.1385T>C | p.Ile462Thr | missense_variant | Exon 8 of 11 | ENST00000371068.11 | NP_060570.2 | |
| EFHC1 | NM_001172420.2 | c.1328T>C | p.Ile443Thr | missense_variant | Exon 9 of 12 | NP_001165891.1 | ||
| EFHC1 | NR_033327.2 | n.2711T>C | non_coding_transcript_exon_variant | Exon 7 of 10 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| EFHC1 | ENST00000371068.11 | c.1385T>C | p.Ile462Thr | missense_variant | Exon 8 of 11 | 1 | NM_018100.4 | ENSP00000360107.4 |
Frequencies
GnomAD3 genomes AF: 0.0000854 AC: 13AN: 152168Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000163 AC: 41AN: 251340 AF XY: 0.000184 show subpopulations
GnomAD4 exome AF: 0.000102 AC: 149AN: 1461838Hom.: 0 Cov.: 32 AF XY: 0.000118 AC XY: 86AN XY: 727220 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000854 AC: 13AN: 152286Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74472 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:2
The I462T variant has not been published as a pathogenic variant, nor has it been reported as a benign polymorphism to our knowledge. It was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The I462T variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved across species. However, missense variants in nearby residues have not been reported in the Human Gene Mutation Database in association with EFHC1-related disorders (Stenson et al., 2014). In silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. -
- -
not specified Uncertain:1
The c.1385T>C (p.I462T) alteration is located in exon 8 (coding exon 8) of the EFHC1 gene. This alteration results from a T to C substitution at nucleotide position 1385, causing the isoleucine (I) at amino acid position 462 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Absence seizure;C0270853:Juvenile myoclonic epilepsy Uncertain:1
- -
Absence seizure;C1850778:Myoclonic epilepsy, juvenile, susceptibility to, 1 Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at